» Articles » PMID: 33426053

LncRNA RHPN1-AS1 Serves As a Sponge for MiR-3133 Modulating the Cell Proliferation of Retinoblastoma Through JAK2

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2021 Jan 11
PMID 33426053
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate the effects of lncRNA RHPN1-AS1 on retinoblastoma (RB) and further explore its underlying molecular mechanisms.

Methods: The expression of RHPN1-AS1, miR-3133, (JAK2), and signal transducer and activator of transcription 3 (STAT3) was detected by qRT-PCR. CCK-8, EDU, and flow cytometry assays were conducted to assess the proliferation activity and apoptosis of RB cells. Double fluorescein and RNA immunoprecipitation assays were performed to detect the interaction between RHPN1-AS1 and miR-3133 or miR-3133 and JAK2. Western blotting was performed to detect the expression of apoptosis-related proteins.

Results: In RB cells, RHPN1-AS1 was upregulated. Silencing RHPN1-AS1 inhibited the activity of RB cells and promoted apoptosis. The expressions of proapoptotic factors (Bax and p53) were increased, while antiapoptotic factors (Bcl-2 and Survivin) were suppressed in siRHPN1-AS1 groups. Furthermore, we predicted and verified that RHPN1-AS1 regulated RB progression by targeting miR-3133/JAK2. In addition, siRHPN1-AS1 also inhibited oncogene STAT3 protein expression.

Conclusion: lncRNA RHPN1-AS1 served as a sponge for miR-3133 to counteract miR-3133-mediated JAK2/STAT3 suppression, indicating that the lncRNA RHPN1-AS1 may be a potential therapeutic target for the treatment of RB.

Citing Articles

miR-3133 inhibits gastrointestinal cancer progression through activation of Hippo and p53 signalling pathways via multi-targets.

Zhou L, Guo H, Liao Q, Zou J, Le Y, Fang Z J Cell Mol Med. 2023; 27(20):3090-3106.

PMID: 37555915 PMC: 10568676. DOI: 10.1111/jcmm.17880.


miR-3133 is an unfavorable prognosis factor and tumor suppressor in colon cancer.

Gao H, Zhang C Funct Integr Genomics. 2023; 23(2):132.

PMID: 37079151 DOI: 10.1007/s10142-023-01059-3.


Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression.

Ahangar Davoodi N, Najafi S, Ghale-Noie Z, Piranviseh A, Mollazadeh S, Ahmadi Asouri S Front Cell Dev Biol. 2023; 10:1065837.

PMID: 36619866 PMC: 9816416. DOI: 10.3389/fcell.2022.1065837.

References
1.
Zhu P, Li Y, Li P, Zhang Y, Wang X . c-Myc induced the regulation of long non-coding RNA RHPN1-AS1 on breast cancer cell proliferation via inhibiting P53. Mol Genet Genomics. 2019; 294(5):1219-1229. DOI: 10.1007/s00438-019-01572-w. View

2.
Chen X . Expression of microRNA-3133 correlates with the prognosis in patients with clear cell renal cell carcinoma. Medicine (Baltimore). 2019; 98(24):e16008. PMC: 6587602. DOI: 10.1097/MD.0000000000016008. View

3.
Mendoza P, Grossniklaus H . Therapeutic Options for Retinoblastoma. Cancer Control. 2016; 23(2):99-109. DOI: 10.1177/107327481602300203. View

4.
Lu L, Yu X, Zhang L, Ding X, Pan H, Wen X . The Long Non-Coding RNA RHPN1-AS1 Promotes Uveal Melanoma Progression. Int J Mol Sci. 2017; 18(1). PMC: 5297855. DOI: 10.3390/ijms18010226. View

5.
Duan H, Li X, Chen Y, Wang Y, Li Z . LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis. Life Sci. 2019; 239:116856. DOI: 10.1016/j.lfs.2019.116856. View